🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase IV, open-label study will evaluate effects of Benralizumab in the tre...
Status
Withdrawn
Location
Baylor University Medical Center
Start Date
2019-12-23
Trial ID
NCT04108962
Treatments Being Tested
The purpose of this study is to find out whether the study drug benralizuma...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2020-09-16
Trial ID
NCT04552288
Treatments Being Tested
This is a study designed to evaluate efficacy and safety of Benralizumab in...
Status
Completed
Location
Research Site
Start Date
2018-08-01
Trial ID
NCT03557307
Treatments Being Tested
The purpose of this study is to investigate the effect of benralizumab on t...
Status
Completed
Location
Research Site
Start Date
2017-07-07
Trial ID
NCT03170271
Treatments Being Tested
The purpose of this study is to determine whether Benralizumab reduces the ...
Status
Terminated
Location
Research Site
Start Date
2013-11
Trial ID
NCT01947946
Treatments Being Tested
The study will evaluate the effect of two intravenous dose regimens of benr...
Status
Completed
Location
Research Site
Start Date
2009-02-02
Trial ID
NCT00768079
Treatments Being Tested
This study evaluates the efficacy and safety of benralizumab as an add-on t...
Status
Recruiting
Location
Research Site
Start Date
2025-03-28
Trial ID
NCT06750289
Treatments Being Tested
This is a multicentre, randomised, open-label, parallel-group, active-contr...
Status
Completed
Location
Research Site
Start Date
2020-07-27
Trial ID
NCT04159519
Treatments Being Tested
This study will assess whether switching participants who have benefitted f...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-26
Trial ID
NCT04718389
The purpose of the investigation is to confirm the safety and efficacy unde...
Status
Completed
Location
Research Site
Start Date
2018-05-31
Trial ID
NCT03588546